Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects

Journal of Internal Medicine

Volumn 245, Issue 2, 1999, Pages 163-174

  Rantala, A O ^a   Kauma, H ^a   Lilja, M ^a   Savolainen, M J ^a   Reunanen, A ^b   Kesaniemi Y A ^a  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Cardiovascular risk factors; Hyperinsulinemia; Hypertension; Metabolic syndrome

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FINLAND; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYNDROME X; URIC ACID BLOOD LEVEL;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HUMANS; HYPERINSULINISM; HYPERLIPIDEMIAS; HYPERTENSION; LOGISTIC MODELS; MALE; METABOLIC DISEASES; MIDDLE AGED; PREVALENCE; RISK FACTORS; SYNDROME;

EID: 0033029112     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00429.x     Document Type: Article

References (67)

1. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M et al. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809-17.
2. Zavaroni I, Bonora E, Pagliara M, Dall'aglio E, Luchetti L, Buonanno G et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl Med 1989; 320: 702-6.
3. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 1988; 37: 338-45.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
5. Reaven GM. Syndrome X: 6 years later. J Int Med 1994; 236 (Suppl. 736): 13-22.
6. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169-73.
7. Eriksson H, Welin L, Wilhelmsen L, Larsson B, Ohlsson L-O, Svärdsudd K et al. Metabolic disturbances in hypertension: results from the population study 'Men born in 1913'. J Int Med 1992; 232: 389-95.
8. American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 1992; 5: 207-9.
9. Hutton P, Dye J, Prys-Roberts C. An assessment of the Dinamap 845. Anaesthesia 1984; 39: 261-7.
10. Silas JH, Barker AT, Ramsay LE. Clinical evaluation of Dinamap 845 automated blood pressure recorder. Br Heart J 1980; 43: 202-5.
11. Khavari KA, Farber PD. A profile instrument for the quantification and assessment of alcohol consumption. The Khavari Alcohol test. J Stud Alcohol 1978; 39: 1525-39.
12. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. (Monograph Series No. 56). Geneva: World Health Organization, 1982.
13. Grimby G. Physical activity and muscle training in the elderly. Acta Med Scand 1986; (Suppl. 711): 233-7.
14. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Bristol, UK: John Wright, 1982.
15. World Health Organization. WHO. Expert Committee on Diabetes Mellitus: Second Report. (Technical Report Series no. 646). Geneva: World Health Organization, 1980.
16. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-22.
17. Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 1992; 20: 38-45.
18. Nilsson P, Andersson DKG, Andersson P-E, Schwan Å, Östlind B, Malmborg R, et al. Cardiovascular risk factors in treated hypertensives - a nation-wide, cross-sectional study in Sweden. J Intern Med 1993; 233: 239-45.
19. Zavaroni I, Mazza S, Dall'aglio E, Gasparini P, Passeri M, Reaven GM. Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med 1992; 231: 235-40.
20. Williams RR, Hunt SC, Hopkins PN, Stults BM, Wu LL, Hasstedt SJ et al. Familial dyslipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988; 259: 3579-86.
21. Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR. Concordance for dyslipidemic hypertension in male twins. JAMA 1991; 265: 2079-84.
22. Muller D, Elahi D, Pratley RE, Tobin JP, Andres R. An epidemiological test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab 1993; 76: 544-8.
23. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-22.
24. Rett K, Wicklmayr M, Jacob S, Tymiec M, Dietze G, Mehnert H. Diagnostische Anhaltspunkte zur Früherkennung des 'metabolischen Syndroms'. Münch Med Wschr 1991; 133: 402-4.
25. Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA 1990; 264: 354-8.
26. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I. Atherosclerotic vascular disease and its risk factors on noninsulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 1988; 11: 449-63.
27. Rönnemaa T, Laakso M, Pyörälä K, Kallio V, Puukka P. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arteriosclerosis Thromb 1991; 11: 80-90.
28. Bursztyn M, Raz I. Blood pressure, glucose, insulin and lipids of young Ethiopian recent immigrants to Israel and in those resident for 2 years. J Hypertens 1993; 11: 455-9.
29. Koutis AD, Lionis CD, Isacsson Å, Jakobsson A, Fioretos M, Lindholm LH. Characteristics of the 'Metabolic Syndrome X' in a cardiovascular low risk population in Crete. Eur Heart J 1992; 13: 865-71.
30. Winocour PH, Kaluvya S, Ramaiya K, Brown L, Millar JP, Farrer M et al. Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women. Arteriosclerosis Thromb 1992; 12: 393-402.
31. Lamarche B, Després J-P, Pouliot M-C, Prud'homme D, Moorjani S, Lupien PJ, et al. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arteriosclerosis Thromb 1993; 13: 31-40.
32. Zimmet PZ, Collins VR, Dowse GK, Alberti KGMM, Tuomilehto J, Knight LT et al. Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Diabetic Med 1994; 11: 388-96.
33. Laws A, King AC, Haskell WL, Reaven GM. Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arteriosclerosis Tromb 1991; 11: 1636-42.
34. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. The Atherosclerosis Risk in Communities Study Investigators. A metabolic syndrome in whites and African-Americans. Diabetes Care 1996; 19: 414-8.
35. National Institutes of Health. The Prevalence Study, Vol. 1. In: Lipid Research Clinics Population Studies Data Book. National Institutes of Health publication 1980; 80-1527. US Dept of Health and Human Services, Public Health Service.
36. Consensus Conference. Treatment of hypertriglyceridemia. JAMA 1984; 251: 1196-200.
37. World Health Organization. Hypertension and Coronary Heart Disease: Classification and Criteria for Epidemiological Studies. (Technical Report Series no. 168). Geneva: World Health Organization, 1959.
38. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell Scientific Publications, 1987.
39. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Int Med 1993; 118: 201-10.
40. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9.5-year follow-up of the Helsinki Policemen Study population. Acta Med Scand 1985; 701 (Suppl. 1): 38-52.
41. Casassus P, Fontbonne A, Thibult N, Ducimetière P, Richard JL, Claude J-R et al. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study. Arteriosclerosis Thromb 1992; 12: 1387-92.
42. Welborn TA, Wearne K. Coronary heart disease and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154-60.
43. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais G, Moorjani S, Lupien P-J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-7.
44. Foster DW. Insulin resistance - a secret killer.? N Engl J Med 1989; 320: 733-4.
45. Kaplan NM. The deadly quartet. Arch Intern Med 1989; 149: 1514-20.
46. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic heart disease. Diabetes Care 1991; 14: 173-94.
47. Cambien F, Warnet J-M, Eschwège E, Jacqueson A, Richard JL, Rosselin G. Body mass, blood pressure, glucose and lipids: does plasma insulin explain their relationships? Arteriosclerosis 1987; 7: 197-202.
48. Mbanya JCN, Thomas TH, Wilkinson R, Alberti KGMM, Taylor R. Hypertension and hyperinsulinemia: a relation in diabetes but not essential hypertension. Lancet 1988; 1: 733-4.
49. Jarrett RJ. Is insulin atherogenic.? Diabetologia 1988; 31: 71-5.
50. Taskinen M-R. Strategies for the diagnosis of metabolic syndrome. Curr Opin Lipidol 1993; 4: 434-43.
51. Frayn KN. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993; 4: 197-204.
52. Després J-P, Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol 1994; 5: 274-89.
53. Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J, Joukamaa M et al. Health, Functional Limitations and Need for Care in Finland. Basic Results from the Mini-Finland Health Survey. Helsinki and Turku, Finland: Publications of the Social Insurance Institution, AL 32, 1989.
54. Nilsson P, Lindholm L, Scherstén B. Hyperinsulinaemia and other metabolic disturbances in well-controlled hypertensive men and women: an epidemiological study of the Dalby population. J Hypertens 1990; 8: 953-59.
55. Poulter NR, Zographos D, Mattin R, Sever PS, Thom SMcG. Concomitant risk factors in hypertensives: a survey of risk factors for cardiovascular disease amongst hypertensives in English general practices. Blood Pressure 1996; 5: 209-15.
56. Tuomilehto J, Puska P, Korhonen H, Mustaniemi H, Vartiainen E, Nissinen A et al. Trends and determinants of ischaemic heart disease mortality in Finland: with special reference to a possible levelling off in the early 1980s. Int J Epidemiol 1989; 18 (Suppl. 1): S109-17.
57. Després J-P, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990; 10: 497-511.
58. Björntorp P. Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med 1992; 24: 15-8.
59. Pouliot M-C, Després J-P, Lemieux S, Moorjani S, Bouchard C, Tremblay A et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-8.
60. Vuorinen-Markkola H, Yki-Järvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25-9.
61. Modan M, Halkin H, Karasik A, Lusky A. Elevated serum uric acid - a facet of hyperinsulinemia. Diabetologia 1987; 30: 713-8.
62. Paolisso G, Ferrannini E, Sgambato S, Varricchio M, D'Onofrio F. Hyperinsulinemia in patients with hypercholesterolemia. J Clin Endocrinol Metab 1992; 75: 1409-12.
63. Karhapää P, Voutilainen E, Kovanen PT, Laakso M. Insulin resistance in familial and nonfamilial hypercholesterolemia. Arteriosclerosis Thromb 1999; 13: 41-7.
64. Yamada Y, Ishizaki M, Kido T, Honda R, Tsuritani I, Yamaya H. Relationship between gamma-glutamyl transpeptidase activity and blood pressure in middle-aged male and female non-drinkers. J Hum Hypertens 1990; 4: 609-14.
65. Lindahl B, Asplund K, Hallmans G. High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The Nothern Sweden Monica population study. J Int Med 1993; 234: 263-70.
66. Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990; 10: 167-75.
67. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57.